While PDGFRA and EGFR amplifications typically demonstrate homogeneous intratumoral distribution [85, 86], EGFRvIII mutations in glioblastomas exhibit marked spatial and temporal intratumoral heterogeneity [87, 88]. The gene discussed is PDGFRA; the disease is glioblastoma.